Lewis T. Williams

2017

In 2017, Lewis T. Williams earned a total compensation of $4.8M as Founder and Executive Chairman at Five Prime Therapeutics, a 41% decrease compared to previous year.

Compensation breakdown

Bonus$198,400
Non-Equity Incentive Plan$351,000
Option Awards$2,852,638
Salary$597,917
Stock Awards$765,788
Other$6,000
Total$4,771,742

Williams received $2.9M in option awards, accounting for 60% of the total pay in 2017.

Williams also received $198.4K in bonus, $351K in non-equity incentive plan, $597.9K in salary, $765.8K in stock awards and $6K in other compensation.

Rankings

In 2017, Lewis T. Williams' compensation ranked 2,022nd out of 14,666 executives tracked by ExecPay. In other words, Williams earned more than 86.2% of executives.

ClassificationRankingPercentile
All
2,022
out of 14,666
86th
Division
Manufacturing
688
out of 5,768
88th
Major group
Chemicals And Allied Products
185
out of 2,074
91st
Industry group
Drugs
138
out of 1,730
92nd
Industry
Pharmaceutical Preparations
105
out of 1,329
92nd
Source: SEC filing on March 30, 2018.

Williams' colleagues

We found four more compensation records of executives who worked with Lewis T. Williams at Five Prime Therapeutics in 2017.

2017

Aron Knickerbocker

Five Prime Therapeutics

Chief Executive Officer

2017

Francis Sarena

Five Prime Therapeutics

Secretary

2017

Helen Collins

Five Prime Therapeutics

Chief Medical Officer

2017

Marc Belsky

Five Prime Therapeutics

Chief Financial Officer

In-depth

You may also like